Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (r)-2-(4-isobutylphenyl)propionylmethanesulfonamide
2. 2-(4-isobutylphenyl)propionylmethanesulfonamide
3. Df 1681y
4. Df-1681y
5. Df1681y
6. Reparixin Lysine
7. Reparixin Lysine Salt
8. Repertaxin
1. Repertaxin
2. 266359-83-5
3. Df 1681y
4. Df1681y
5. Reparixin (repertaxin)
6. (r)-2-(4-isobutylphenyl)-n-(methylsulfonyl)propanamide
7. Df-1681y
8. Chembl191413
9. U604e1nb3k
10. 266359-83-5 (free Base)
11. Reparixin [inn]
12. (2r)-2-[4-(2-methylpropyl)phenyl]-n-methylsulfonylpropanamide
13. Reparixin [usan:inn]
14. Unii-u604e1nb3k
15. (2r)-2-(4-(2-methylpropyl)phenyl)-n-methylsulfonylpropanamide
16. 2-(4-isobutylphenyl)propionylmethanesulfonamide
17. Reparixin (usan/inn)
18. Reparixin [usan]
19. Reparixin [mart.]
20. Reparixin [who-dd]
21. Dsstox_cid_26509
22. Dsstox_rid_81678
23. Dsstox_gsid_46509
24. Gtpl8498
25. Schembl1884299
26. Zinc8717
27. Dtxsid6046509
28. Chebi:177765
29. Bcp10635
30. Ex-a2461
31. Tox21_112272
32. Bdbm50169045
33. Mfcd18633292
34. S8640
35. Ccg-267282
36. Cs-1379
37. Db12614
38. Benzeneacetamide, Alpha-methyl-4-(2-methylpropyl)-n-(methylsulfonyl)-, (alphar)-
39. Ac-32023
40. Bs-16754
41. Hy-15251
42. Cas-266359-83-5
43. D08984
44. Q27088533
45. (2r)-2-[4-(2-methylpropyl)phenyl]-n-methylsulonylpropanamide
46. N-[(r)-2-(4-isobutyl-phenyl)-propionyl]-methanesulfonamide
47. Benzeneacetamide, Alpha-methyl-4-(2-methylpropyl)-n-(methylsulfonyl)- (alphar)-
48. Benzeneacetamide, .alpha.-methyl-4-(2-methylpropyl)-n-(methylsulfonyl)-, (.alpha.r)-
| Molecular Weight | 283.39 g/mol |
|---|---|
| Molecular Formula | C14H21NO3S |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 5 |
| Exact Mass | 283.12421471 g/mol |
| Monoisotopic Mass | 283.12421471 g/mol |
| Topological Polar Surface Area | 71.6 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 389 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Prevention of graft rejection
Treatment of coronavirus disease 2019 (COVID-2019)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Reparixin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Reparixin, including repackagers and relabelers. The FDA regulates Reparixin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Reparixin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Reparixin supplier is an individual or a company that provides Reparixin active pharmaceutical ingredient (API) or Reparixin finished formulations upon request. The Reparixin suppliers may include Reparixin API manufacturers, exporters, distributors and traders.
Reparixin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Reparixin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Reparixin GMP manufacturer or Reparixin GMP API supplier for your needs.
A Reparixin CoA (Certificate of Analysis) is a formal document that attests to Reparixin's compliance with Reparixin specifications and serves as a tool for batch-level quality control.
Reparixin CoA mostly includes findings from lab analyses of a specific batch. For each Reparixin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Reparixin may be tested according to a variety of international standards, such as European Pharmacopoeia (Reparixin EP), Reparixin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Reparixin USP).
LOOKING FOR A SUPPLIER?
